Neurogene, Inc. Common Stock
$28.31
▼ 2.94
(-9.41%)
Volume: 200,066
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
13
- 21d momentum -26.3%
- MA aligned bearish
- RSI 30
🎯
Pullback
66
- RSI 30 near lows
- Near lower Bollinger band
- -18.8% vs 20MA
💎
Value
58
- -35% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)30.1
MACD-0.726
MA trendBearish
ATR8.15%
21d mom.-26.3%
63d mom.-11.6%
vs 20MA-18.8%
RVOL(20)0.63×
52w low · 16
52w high · 44
-35.2% from 52-week high
20d support 28
· resistance 40
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$625M
PER—
PBR2.88
PSR—
EPS$-5.55
ROE-51.2%
ROA-45.5%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-4.34
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -11.78% | -26.30% | -11.61% | +32.23% | +64.12% | +40.43% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -26.66%, daily vol 4.08%. Neurogene, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.